XML 42 R39.htm IDEA: XBRL DOCUMENT v3.19.3
Derivative Instruments And Hedging Activities (Tables)
 9 Months Ended
Sep. 30, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of balance sheet location and fair value of derivative instruments designated as hedging instruments
The following table presents the balance sheet location and fair value of our derivative instruments that were designated as hedging instruments (in thousands):
 
September 30, 2019
 
December 31, 2018
 
Balance Sheet
Location
 
Fair
Value
 
Balance Sheet
Location
 
Fair
Value
Asset Derivative Instruments:
 
 
 
 
 
 
 
Interest rate swaps
Other current assets
 
$
108

 
Other current assets
 
$
863

Interest rate swaps
Other assets, net
 
—

 
Other assets, net
 
201

 
 
 
$
108

 
 
 
$
1,064

 
 
 
 
 
 
 
 
Liability Derivative Instruments:
 
 
 
 
 
 
 
Foreign exchange contracts
Accrued liabilities
 
$
1,089

 
Accrued liabilities
 
$
5,857

Foreign exchange contracts
Other non-current liabilities
 
—

 
Other non-current liabilities
 
354

 
 
 
$
1,089

 
 
 
$
6,211
Schedule of balance sheet location and fair value of derivative instruments not designated as hedging instruments
The following table presents the balance sheet location and fair value of our derivative instruments that were not designated as hedging instruments (in thousands):
 
September 30, 2019
 
December 31, 2018
 
Balance Sheet
Location
 
Fair
Value
 
Balance Sheet
Location
 
Fair
Value
Liability Derivative Instruments:
 
 
 
 
 
 
 
Foreign exchange contracts
Accrued liabilities
 
$
1,634

 
Accrued liabilities
 
$
3,454

Foreign exchange contracts
Other non-current liabilities
 
—

 
Other non-current liabilities
 
530

 
 
 
$
1,634

 
 
 
$
3,984
Schedule of unrealized gain (loss) recognized in OCI
The following tables present the impact that derivative instruments designated as hedging instruments had on our accumulated OCI (net of tax) and our condensed consolidated statements of operations (in thousands). We estimate that as of September 30, 2019, $0.8 million of net losses in accumulated OCI associated with our derivative instruments is expected to be reclassified into earnings within the next 12 months.
 
 
Unrealized Gain (Loss) Recognized in OCI
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
 
2019
 
2018
 
2019
 
2018
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
 
$
(280
)
 
$
(164
)
 
$
(338
)
 
$
(35
)
Interest rate swaps
 
6

 
76

 
(363
)
 
874

 
 
$
(274
)
 
$
(88
)
 
$
(701
)
 
$
839
Schedule of gain (loss) reclassified from Accumulated OCI into earnings
 
Location of Gain (Loss) Reclassified from
Accumulated OCI into Earnings
 
Gain (Loss) Reclassified from
Accumulated OCI into Earnings
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
 
2019
 
2018
 
2019
 
2018
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
Cost of sales
 
$
(1,197
)
 
$
(1,957
)
 
$
(5,460
)
 
$
(5,538
)
Interest rate swaps
Net interest expense
 
151

 
158

 
593

 
305

 
 
 
$
(1,046
)
 
$
(1,799
)
 
$
(4,867
)
 
$
(5,233
)
Schedule of impact of derivative instruments not designated as hedging instruments on condensed consolidated statements of operations
The following table presents the impact that derivative instruments not designated as hedging instruments had on our condensed consolidated statements of operations (in thousands):
 
Location of Loss
Recognized in Earnings
 
Loss Recognized in Earnings
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
 
2019
 
2018
 
2019
 
2018
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
Other expense, net
 
$
(371
)
 
$
(83
)
 
$
(413
)
 
$
(26
)
 
 
 
$
(371
)
 
$
(83
)
 
$
(413
)
 
$
(26
)